Our results suggest that the inability of cells with FBW7 point mutations and truncations to suppress c-Myc and Mcl-1 may contribute to chemotherapy resistance in cancers lacking the sixth WD domain (Ye et al., 2017). The gene discussed is MCL1; the disease is cancer.